drugset / Trial / NCT00659100

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

NCT00659100

Phase 3 Completed 1254 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (OTC) product label.

Timeline

Start
2006-08
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 50 mg Oral

Indications